These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16288986)

  • 1. PPARalpha activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism.
    Ren S; Xin C; Beck KF; Saleem MA; Mathieson P; Pavenstädt H; Pfeilschifter J; Huwiler A
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1818-24. PubMed ID: 16288986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes.
    Huwiler A; Ren S; Holthöfer H; Pavenstädt H; Pfeilschifter J
    Biochem Biophys Res Commun; 2003 May; 305(1):136-42. PubMed ID: 12732207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway.
    Takano Y; Yamauchi K; Hayakawa K; Hiramatsu N; Kasai A; Okamura M; Yokouchi M; Shitamura A; Yao J; Kitamura M
    FEBS Lett; 2007 Feb; 581(3):421-6. PubMed ID: 17239861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.
    Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
    Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
    J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy.
    Doublier S; Zennaro C; Spatola T; Lupia E; Bottelli A; Deregibus MC; Carraro M; Conaldi PG; Camussi G
    AIDS; 2007 Feb; 21(4):423-32. PubMed ID: 17301560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin.
    Takano Y; Yamauchi K; Hiramatsu N; Kasai A; Hayakawa K; Yokouchi M; Yao J; Kitamura M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1573-82. PubMed ID: 17244893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.
    Okamura M; Takano Y; Saito Y; Yao J; Kitamura M
    Nephrol Dial Transplant; 2009 Oct; 24(10):3006-12. PubMed ID: 19474283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrin mRNA regulation by protein kinase C.
    Wang SX; Menè P; Holthöfer H
    J Nephrol; 2001; 14(2):98-103. PubMed ID: 11411021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
    Murakami K; Bujo H; Unoki H; Saito Y
    Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of nephrin gene by the Ets transcription factor, GA-binding protein.
    Ristola M; Arpiainen S; Shimokawa T; Ra C; Tienari J; Saleem MA; Holthöfer H; Lehtonen S
    Nephrol Dial Transplant; 2013 Apr; 28(4):846-55. PubMed ID: 23197680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
    Grau R; Punzón C; Fresno M; Iñiguez MA
    Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-κB and silenced by DNA methylation.
    Ristola M; Arpiainen S; Saleem MA; Holthöfer H; Lehtonen S
    Nephrol Dial Transplant; 2012 May; 27(5):1737-45. PubMed ID: 21980157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.
    Bondeva T; Roger T; Wolf G
    Am J Nephrol; 2007; 27(3):308-14. PubMed ID: 17495427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases.
    Ikezumi Y; Suzuki T; Karasawa T; Kawachi H; Nikolic-Paterson DJ; Uchiyama M
    Biochem Biophys Res Commun; 2008 Nov; 376(4):706-11. PubMed ID: 18809387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
    Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
    Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
    Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
    Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
    Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
    Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.